Ophthalmology Volume 123, Number 3, March 2016 Descemet stripping endothelial keratoplasty. Arch Ophthalmol 3. Kopplin LJ, Przepyszny K, Schmotzer B, et al. Relationship of Fuchs endothelial corneal dystrophy severity to central corneal thickness. Arch Ophthalmol 2012;130:433–9. 4. Wacker K, McLaren JW, Amin SR, et al. Corneal high-order aberrations and backscatter in Fuchs’ endothelial corneal dys- trophy. Ophthalmology 2015;122:1645–52. 5. McLaren JW, Bachman LA, Kane KM, Patel SV. Objective assessment of the corneal endothelium in Fuchs’ endothelial dystrophy. Invest Ophthalmol Vis Sci 2014;55:1184–90. Re: Spaide et al.: Volume-rendering optical coherence tomography angio- graphy of macular telangiectasia type 2 (Ophthalmology 2015;122:2261-9) We agree very much with Spaide et al 1 that a great advantage of optical coherence tomography (OCT) angiography is its 3-dimensional (3D) nature, and that color coding for the depth of vessels is a natural way to represent this 3D information. However, we think it is disingenuous for Dr Spaide to imply that he was the first to adapt this approach from CT and MR literature and apply it to OCT angiography. He wrote: TO THE EDITOR: Instead of imaging the average or densest voxel, volume rendering uses all the voxel values to make an image that retains the sense of depth and is less prone to image artifact. These methods were adapted to OCTA, which does not use dye, by Dr. Spaide. In fact, volume rendering of angiography and color coding of vessel depth had already been used by several groups since the early days of OCT angiography. Barton et al 2 reported volume rendering of skin vasculature detected by Doppler OCT as early as 1999. Zhao et al 3 had described 3D volume-rendered Doppler OCT angi- ography of port wine stain vasculature by 2001. Yasuno et al had described 3D volume-rendered OCT angiography of in vivo human macular and optic nerve head vessels in 2006. 4 Wang et al (Optics Express 2007) had shown 3D volume rendering of mouse cortical vessels. Fingler et al (Optics Express 2009) had demonstrated volume rendering of human retinal microvasculature. Vakoc et al (Nature Medicine 2009) had used color coding to render complex 3D vasculature in tumor and brain layers using OCT angiography. Mariampillai et al (Optics Letters), Srinivasan et al (Optics Letters), and Yu et al (Journal of Biomedical Optics) had all used volume rendering to visualize 3D vascular structures in 2010. Jia et al (Proceedings of the National Academy of Sciences 2015) had used color to separate shallower retinal circulation from deeper choroidal circulation using the en face slab visualization approach, as did Kim et al (Proceedings of the National Academy of Sciences 2013) for visualizing vascular beds in geographic atrophy. And pixel transparency of the retinal slab was adjusted to optimize the visualization of choroidal neovascularization. 5 We list these prior works here so the reader can appreciate the work of pioneers in this field. Z HONGPING C HEN , P H D 1 D AVID H UANG , MD, P H D 2 J OSEPH A. I ZATT , P H D 3 R UIKANG K. W ANG , P H D 4 e24 J OHN S. W ERNER , P H D 5 Y OSHIAKI Y ASUNO , P H D 6 Department of Biomedical Engineering, University of California at Irvine, Irvine, California; 2 Casey Eye Institute, Oregon Health & Science University, Portland, Oregon; 3 Department of Biomedical Engineering, Duke University, Durham, North Carolina; 4 Department of Biomedical Engineering, University of Washington, Seattle, Washington; 5 Department of Ophthalmology, University of California at Davis, Sacramento, California; 6 Institute of Applied Physics, University of Tsukuba, Tsukuba, Japan Financial Disclosure(s): The authors made the following disclosures: Z.C.: Grants e NIH, during the conduct of the study; Personal fees and Other: OCT Medical Imaging Inc., outside the submitted work; Patent pending, a patent issued, a patent licensed, and a patent with royalties paid. D.H.: has a significant financial interest in Carl Zeiss Meditec; Oregon Health & Science University (OHSU) and Dr. Huang has a significant financial interest in Optovue, Inc., a company that may have a commercial interest in the results of this research and technology. These potential conflicts of interest have been reviewed and managed by OHSU. J.A.I.: US Patent No. 6,735,463, “Doppler Flow Imaging Using Optical Coherence Tomography” with royalties paid to Leica Microsystems, Inc. R.K.W.: Grants e National Institutes of Health; Grants and Nonfinancial support e Carl Zeiss Meditec Inc., outside the submitted work. In addition, Dr. Wang has a patent Oregon Health & Science University with royalties paid to Carl Zeiss Meditec, Inc., and a patent University of Washington pending. Y.Y.: Grants e Japan Society for the Promotion of Science, Japan Science and Technology Agency, Topcon Corp., Nidek Inc., Canon, during the conduct of the study; Grants e Tomey Corp., outside the submitted work. Correspondence: David Huang, MD, PhD, Oregon Health & Science University, 3375 SW Terwilliger Boulevard, Portland, OR 97239. E-mail: davidhuang@ alum.mit.edu. References 1. Spaide RF, Klancnik JM Jr, Cooney MJ, et al. Volume- rendering optical coherence tomography angiography of macular telangiectasia type 2. Ophthalmology 2015;122:2261–9. 2. Kehlet Barton J, Izatt JA, Kulkarni MD, et al. Three-dimensional reconstruction of blood vessels from in vivo color Doppler op- tical coherence tomography images. Dermatology 1999;198: 3. Zhao Y, Brecke KM, Ren H, et al. Three-dimensional recon- struction of in vivo blood vessels in human skin using phase- resolved optical Doppler tomography. IEEE J Sel Top Quantum Electron 2001;7:931–5. 4. Makita S, Hong Y, Yamanari M, et al. Optical coherence angiography. Opt Express 2006;14:7821–40. 5. Jia Y, Bailey ST, Hwang TS, et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A 2015;112:E2395–402. We wish to thank the authors for their letter and also thank them for reading our paper. 1 Volume rendering has been used in representation of both computed tomography and magnetic resonance imaging for more than 3 decades. Thus, the techniques used in our paper are not new. We suggest reading the quoted sentence in the context of the paragraph in which it was embedded. We stated that the previous REPLY